Synairgen (SNG) Competitors GBX 4.62 0.00 (0.00%) (As of 11/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines SNG vs. COS, SBTX, C4XD, DDDD, AREC, SAR, OKYO, OBI, AOR, and HEMOShould you be buying Synairgen stock or one of its competitors? The main competitors of Synairgen include Collagen Solutions plc (COS.L) (COS), SkinBioTherapeutics (SBTX), C4X Discovery (C4XD), 4D pharma (DDDD), Arecor Therapeutics (AREC), Sareum (SAR), OKYO Pharma (OKYO), Ondine Biomedical (OBI), AorTech International (AOR), and Hemogenyx Pharmaceuticals (HEMO). These companies are all part of the "biotechnology" industry. Synairgen vs. Collagen Solutions plc (COS.L) SkinBioTherapeutics C4X Discovery 4D pharma Arecor Therapeutics Sareum OKYO Pharma Ondine Biomedical AorTech International Hemogenyx Pharmaceuticals Synairgen (LON:SNG) and Collagen Solutions plc (COS.L) (LON:COS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings. Which has stronger valuation & earnings, SNG or COS? Collagen Solutions plc (COS.L) has higher revenue and earnings than Synairgen. Synairgen is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynairgen£79K117.77-£42.87M-£0.03-154.00Collagen Solutions plc (COS.L)£4.01M0.00N/A-£0.80N/A Does the media prefer SNG or COS? In the previous week, Synairgen's average media sentiment score of 0.00 equaled Collagen Solutions plc (COS.L)'saverage media sentiment score. Company Overall Sentiment Synairgen Neutral Collagen Solutions plc (COS.L) Neutral Do insiders and institutionals believe in SNG or COS? 30.7% of Synairgen shares are held by institutional investors. 3.2% of Synairgen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is SNG or COS more profitable? Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat Synairgen's return on equity.Company Net Margins Return on Equity Return on Assets SynairgenN/A -48.86% -30.58% Collagen Solutions plc (COS.L) N/A N/A N/A Does the MarketBeat Community favor SNG or COS? Synairgen received 24 more outperform votes than Collagen Solutions plc (COS.L) when rated by MarketBeat users. However, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 56.46% of users gave Synairgen an outperform vote. CompanyUnderperformOutperformSynairgenOutperform Votes15356.46% Underperform Votes11843.54% Collagen Solutions plc (COS.L)Outperform Votes12972.88% Underperform Votes4827.12% SummaryCollagen Solutions plc (COS.L) beats Synairgen on 5 of the 9 factors compared between the two stocks. Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNG vs. The Competition Export to ExcelMetricSynairgenBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£9.30M£181.60M£4.98B£1.14BDividend Yield1.53%3.54%7.77%11.45%P/E Ratio-149.63186.7384.831,595.27Price / Sales117.7717,456.521,387.25228,485.71Price / Cash1.9011.4333.4033.63Price / Book0.187.484.672.84Net Income-£42.87M-£19.46M£115.27M£146.23M7 Day Performance8.45%7.53%-2.96%4.19%1 Month Performance-3.55%9.89%-4.00%2.69%1 Year Performance-30.53%29.56%30.36%126.35% Synairgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGSynairgenN/AGBX 4.62flatN/A-32.8%£9.30M£79,000.00-149.6334COSCollagen Solutions plc (COS.L)N/AGBX 6.63flatN/A+0.0%£30.99M£4.01M-8.283,350SBTXSkinBioTherapeuticsN/AGBX 13.50-1.8%N/A-30.5%£30.52M£21,949.00-675.0011News CoverageC4XDC4X DiscoveryN/AGBX 12+27.3%N/A-3.8%£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AGBX 16.66flatN/AN/A£30.05M£718,000.00-1.08106ARECArecor TherapeuticsN/AGBX 76flatN/A-58.8%£28.70M£4.90M-271.4310News CoverageSARSareumN/AGBX 24.85+1.4%N/A-60.8%£26.83M£47,204.00-414.173,211OKYOOKYO PharmaN/AGBX 1.40-24.3%N/AN/A£23.24MN/A-140.007Gap DownOBIOndine BiomedicalN/AGBX 8.13+1.6%N/A-10.7%£22.53M£1.63M-270.83N/AGap UpAORAorTech InternationalN/AGBX 123.50-2.4%N/A+0.0%£19.99M£539,000.00-33.383HEMOHemogenyx PharmaceuticalsN/AGBX 1.09+3.6%N/A-45.6%£14.57MN/A-108.7014Gap Down Related Companies and Tools Related Companies Collagen Solutions plc (COS.L) Competitors SkinBioTherapeutics Competitors C4X Discovery Competitors 4D pharma Competitors Arecor Therapeutics Competitors Sareum Competitors OKYO Pharma Competitors Ondine Biomedical Competitors AorTech International Competitors Hemogenyx Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SNG) was last updated on 11/19/2024 by MarketBeat.com Staff From Our PartnersTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synairgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.